The neurorehabilitation devices market has seen considerable growth due to a variety of factors.
• In the last few years, the neurorehabilitation devices market has seen rapid growth. The market, which stood at $1.85 billion in 2024, is predicted to reach $2.07 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.9%.
Factors like the increasingly ageing population, high occurrence of neurodegenerative diseases, amplified awareness, assistance from regulatory bodies, and enhancement in research and development have all contributed to the growth seen in the historical span.
The neurorehabilitation devices market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for a swift expansion of the neurorehabilitation devices market in the coming years, with projections estimating a growth to $3.21 billion in 2029 and a compound annual growth rate (CAGR) of 11.6%.
Multiple factors link to the predicted growth in this forecast period, namely the surge in healthcare investments, better-informed healthcare professionals, the rise of telemedicine and specialty clinics, and enhanced patient results. The period forecast also anticipates several emerging trends, such as advancements in technology, the introduction of artificial intelligence and robotics in neurorehabilitation devices, the use of wearable neurorehabilitation gadgets, and the capabilities of real-time data to enable constant monitoring.
Growth in the neurorehabilitation devices market is anticipated to surge due to the rising incidence of neurological disorders. Factors such as an aging populace, enhanced diagnostic procedures, heightened awareness, stress, and mental health issues contribute to the expanding cases of neurological disorders. Neurorehabilitation devices address these disorders through supportive rehabilitation by reviving motor, sensory, and cognitive functions via specific therapies and stimulation. The World Federation of Neurology reported in October 2023, a UK-based organization for neurologists globally, that over 40% of the world's population suffers from some type of neurological disorder, and this number is projected to almost double by 2050. Moreover, according to a September 2021 statement by the UK Parliament, approximately one-sixth of the UK population suffers from at least a single neurological condition, with an estimated 600,000 new diagnoses annually. As a consequence, the escalating incidence of neurological disorders fuels the expansion of the market for neurorehabilitation devices.
The neurorehabilitation devices market covered in this report is segmented –
1) By Product: Neurorobotics, Brain-Computer Interface, Wearable Devices, Non-Invasive Stimulators, Other Products
2) By Application: Stroke, Parkinson's Disease, Brain And Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis, Other Applications
3) By End User: Rehabilitation Centers, Hospitals And Clinics, Home Care, Other End Users
Subsegments:
1) By Neurorobotics: Robotic Exoskeletons, Robotic Rehabilitation Devices, Assistive Robots For Gait Training
2) By Brain-Computer Interface: Invasive Brain-Computer Interfaces, Non-Invasive Brain-Computer Interfaces, Hybrid Brain-Computer Interfaces
3) By Wearable Devices: Smart Gloves, Smart Sensors, Exosuits and Wearable Robotics
4) By Non-Invasive Stimulators: Transcranial Magnetic Stimulation (TMS) Devices, Transcranial Direct Current Stimulation (tDCS) Devices, Functional Electrical Stimulation (FES) Devices
5) By Other Products: Virtual Reality Rehabilitation Systems, Software Platforms For Neurorehabilitation, Cognitive Training Devices
Leading businesses in the neurorehabilitation devices market are prioritizing the development of inventive products, including hyper-sensitive controllers, to increase accuracy and patient engagement during rehabilitation treatments. A hyper-sensitive controller is a component or system engineered to react with significant sensitivity to a user's motions, intentions, or brain signals. For example, MindMaze, a Switzerland-based company specializing in digital neurotherapeutics (DTx) solutions, unveiled Izar in February 2023. This groundbreaking, high-tech peripheral equipment is devised to improve hand motor skills in patients experiencing neurological conditions such as stroke and Parkinson's disease. It precisely monitors delicate grasping forces and wrist movements enhancing hand agility and strength. Izar allows meticulous training and assessment and is adaptable for both in-clinic and at-home self-training, catering to an essential requirement in neurological rehabilitation.
Major companies operating in the neurorehabilitation devices market are:
• ReWalk Robotics Ltd.
• Ottobock SE & Co. KGaA
• Helius Medical Technologies Inc.
• Bioventus LLC
• Bioness Inc.
• Neofect Co. Ltd.
• Tyromotion GmbH
• Ekso Bionics Holdings Inc.
• Reha Technology AG
• Ectron Ltd.
• Biometrics Ltd.
• BioXtreme Ltd.
• Eodyne LLC
• Kinestica Inc.
• Medimotion
• Motus Nova
• NeuroGym
• NeuroMetrix Inc.
• Rehab-Robotics Company Limited
• Rex Bionics Ltd.
• Saebo Inc.
• Bionik Laboratories Corp
North America was the largest region in the neurorehabilitation devices market in 2024. The regions covered in the neurorehabilitation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.